ARPA-H Selects Three Teams in $100M Effort to Repair and Regrow Ailing Joints
ARPA-H announced a $100 million program to fund clinical trials for joint regeneration. Three leading academic centers were selected to test innovative therapies aimed at repairing and regrowing damaged cartilage and bone. The projects will explore senolytic drugs, engineered tissue scaffolds, and gene‑editing techniques in human participants. The initiative marks the first federal effort to fast‑track regenerative solutions for age‑related joint disease.
What Is Longevity Medicine and How Do You Navigate It?
Longevity medicine, also known as geromedicine, lacks formal board certification or standardized guidelines in the United States, allowing any physician to market themselves as a longevity specialist. While some clinicians genuinely aim to extend healthy lifespan through personalized, preventive care,...
Cymbiotika Partners with Gary Brecka for Precision Wellness
A wave of strategic collaborations is reshaping the longevity and digital health landscape. Cymbiotika has partnered with wellness futurist Gary Brecka to launch precision‑wellness offerings, while Beacon Biosignals secured more than $97 million in a Series B round. WELL Health announced two...
HexemBio Raises $10.4M Seed for Stem Cell Rejuvenation
HexemBio announced a $10.4 million seed round, led by Draper Associates with participation from SOSV, Seraphim and other investors. The biotech is developing a Synthetic Human Yolk Sac that temporarily houses a patient’s blood stem cells to rejuvenate their function before...
Gene Regulation May Control How Long We Live
A recent cross‑species analysis reveals that alternative splicing—a cellular process that edits gene messages—forms a distinct layer of lifespan regulation in mammals. Researchers examined six tissues across 26 species and identified 731 splicing events whose patterns correlate with maximum lifespan....
Your Vitamin D Levels in Midlife Could Shape Your Brain Decades Later
A 16‑year longitudinal study of 793 middle‑aged adults found that higher vitamin D levels in their 30s‑40s were associated with lower tau protein accumulation later, a biomarker linked to Alzheimer’s disease. Participants with vitamin D above 30 ng/mL showed reduced tau...
Polyunsaturated Lipids Kill Senescent Cells by Ferroptosis
Researchers led by Zhang published in Cell Press Blue identified two polyunsaturated lipids that selectively trigger ferroptosis in senescent cells. The study demonstrates that senescent cells are uniquely vulnerable to iron‑dependent lipid peroxidation, and that these lipids can clear them...
Vitamin C Slows Primate Aging by Targeting Iron-Driven Lipid Peroxidation
Researchers led by Liu et al. identified a conserved iron‑driven lipid peroxidation pathway that accelerates aging in primates, mediated by the enzyme ACSL4. The study demonstrates that vitamin C directly binds and inhibits ACSL4, curbing ferroptotic damage and extending healthspan...
Microplastics in Human Bile Drive Mitochondrial Dysfunction and Senescence
Researchers have identified microplastics in the bile of all 14 patients studied, revealing six polymer types dominated by PET and polyethylene. Patients with gallstones carried significantly higher microplastic loads, suggesting bile stasis may promote retention. Laboratory exposure of cholangiocytes to...
Low-Cost, Single Sample Blood Test Detects Different Cancers, Liver Disorders, and Other Diseases
UCLA researchers unveiled MethylScan, a low‑cost blood test that analyzes cell‑free DNA methylation to detect multiple cancers and liver disorders in a single sample. By using methylation‑sensitive enzymes to strip away background DNA, the assay reduces sequencing needs to about...
WELL Health Partners with AliveCor for Cardiac Monitoring in Canada
WELL Health announced a partnership with AliveCor to bring the Kardia mobile ECG platform to Canadian patients. The collaboration enables remote cardiac monitoring and real‑time cardiologist review through WELL Health’s telehealth network. By integrating AliveCor’s FDA‑cleared devices, the service aims...
Nanotube Injector Boosts Mitochondrial Performance Through Cytoplasmic Transfer
Researchers at Waseda University unveiled a gold‑membrane nanotube injector that can extract and deliver cytoplasmic material—including intact mitochondria—between living cells. By fine‑tuning nanotube dimensions and internal air pressure, the system achieves over 90% transfer efficiency while preserving roughly 95% cell...
Catalyst Precision Health Debuts At-Home Men’s Longevity Care
Catalyst Precision Health, a New York startup founded by Mount Sinai physician Dr. Westley Spiro and entrepreneur Matt Renart, has launched what it calls the first men’s longevity service that unites in‑home lab testing, physician house calls, and continuous personalized...
Agentis, Ultrahuman Tie Wearables to Longevity Care
Agentis Longevity and Ultrahuman have announced a strategic partnership that links Ultrahuman’s wearable biosensor platform with Agentis’ proprietary Longevity Quotient (LQ) score. Continuous glucose monitoring and recovery analytics will feed real‑time data into the LQ, turning a static health snapshot...
Noom Buys Pharmacy to Push Into Healthy Aging
Noom, the behavior‑change app best known for weight‑loss coaching, has completed its acquisition of Tailor Made Compounding, a licensed 503A pharmacy operating in 46 U.S. states. The purchase gives Noom direct control over compounding services, enabling it to offer prescription‑grade...
Toward the Simultaneous Detection of Multiple Diseases with a Highly Cost-Effective Cell-Free DNA Methylome Test
Researchers introduced MethylScan, a low‑cost cell‑free DNA methylome sequencing assay that profiles the entire cfDNA methylome from a single blood draw. In a cohort of 1,061 individuals, the test achieved an AUROC of 0.938 for multicancer detection (63.3% sensitivity at...
Medicines Watchdog to Investigate UK Peptide Clinics over Health Claims
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has launched an investigation into several peptide clinics that are promoting unregulated, experimental peptide injections as medicinal treatments. Clinics are advertising products such as BPC‑157, Cortexin and Thymosin Alpha with claims...
What Are Peptides, Are They Safe and Is There Evidence to Back up the Hype?
Peptides—short chains of amino acids—are gaining popularity for weight loss, anti‑aging, and injury recovery. While prescription drugs like semaglutide and tirzepatide are FDA‑approved, most products marketed online are experimental, unregulated compounds such as BPC‑157, TB‑500, and CJC‑1295. Scientific reviews show...
Neuronal HDAC9: A Key Regulator of Cognitive and Synaptic Aging, Rescuing Alzheimer’s Disease-Related Phenotypes
Recent research identifies neuronal HDAC9 as a pivotal regulator of synaptic health and cognition during aging. The study shows that HDAC9 expression declines in the cortex of Alzheimer’s disease (AD) patients and aged mice, correlating with synaptic loss and memory...
Curve Bio Strengthens Clinical Push with CMO Hire
Curve Biosciences, the whole‑body intelligence company, announced the appointment of hepatology expert Dr. Amit Singal as chief medical officer. The hire follows a $40 million financing round and signals the firm’s shift from platform development to clinical implementation, starting with liver...
Occupational Health Meets Longevity
Occupational health is evolving from a compliance‑focused function to a preventive longevity platform, aiming to influence how employees age. Executives are urged to prioritize five key areas, including midlife interventions, data‑driven health monitoring, and navigating privacy challenges. Employers see longevity...
Prediabetes May Need a Tailored Treatment Rethink
Researchers presented new data on 662 U.S. adults aged 18‑40 with prediabetes, revealing that the average five‑year risk of progressing to type 2 diabetes is 7.5%. The risk climbs to 10.9% for those meeting GLP‑1 receptor agonist (GLP‑1RA) weight‑loss criteria, 15.1%...
Superpower Partners with Grail to Add Galleri Cancer Screening
Superpower, a technology‑driven health benefits platform, announced a partnership with Grail to incorporate the Galleri multi‑cancer blood test into its member offerings. Galleri screens for more than 50 cancer types using DNA methylation signatures and has received FDA clearance for...
Designs for Health Launches NeuroCalm Peptide for Gut-Brain Support
Designs for Health has introduced NeuroCalm Peptide, a once‑daily capsule formulated to support the gut‑brain axis. The product combines the milk‑derived peptide Lactium with heat‑treated Lactobacillus gasseri CP2305, a postbiotic shown to influence stress markers. Clinical data cited by the...
Depression, but Not Anxiety, Is Associated with Epigenetic Age Accelerations Among Asian Older Adults
A new molecular psychiatry study of 672 community‑dwelling older Asian adults found that higher depressive symptom severity is associated with accelerated epigenetic aging, especially measured by the second‑generation PC‑PhenoEAA clock (β = 0.087 per standard‑deviation increase; clinical depression raises PC‑PhenoEAA by 0.24 SD)....
Higher Vitamin D in Midlife May Be Associated with Lower Levels of Alzheimer’s Biomarker Years Later
Researchers at University of Galway analyzed data from 793 adults in the Framingham Heart Study, measuring vitamin D levels in their late 30s and performing tau PET scans 16 years later. They found that participants with higher circulating 25‑hydroxyvitamin D...
How Old Is Your Brain, Exactly? Brain Age May Impact Dementia Risk
Researchers applied a machine‑learning model to sleep‑EEG recordings from more than 7,000 participants, generating a “brain age” index that reflects how fast the brain appears to age. The analysis showed that a brain age ten years older than a person’s...
SpectraCell Packages Longevity, Early Disease Detection in One Kit
SpectraCell Laboratories introduced Baseline Nexus, a bundled diagnostic kit that merges four flagship tests—micronutrient profiling, lipoprotein particle analysis, telomere length measurement, and MTHFR genotyping—into a single service. The package aims to reveal hidden nutrient deficiencies, cardiovascular risk, biological aging, and...
Agentis, Ultrahuman Tie Wearables to Longevity Quotient
Agentis Longevity and Ultrahuman announced a strategic partnership to fuse Ultrahuman’s real‑time wearable and continuous glucose monitoring data with Agentis’ proprietary Longevity Quotient (LQ) score. The combined platform will deliver a continuous health score that translates biosensor readings into actionable...
I-Lumen Receives FDA IDE to Start US I-SIGHT2 Enrollment
I‑Lumen announced that the U.S. Food and Drug Administration has granted an Investigational Device Exemption (IDE) for its i‑SIGHT2 clinical study. The clearance allows the company to begin enrolling participants in the United States to evaluate its breath‑based metabolic monitoring...
Sauna and Cold Plunge: Where Does the Evidence Stand? – Podcast
A new Science Weekly podcast examines the growing trend of alternating sauna sessions and cold‑plunge immersions, dissecting the scientific evidence behind claimed health benefits. Researchers discuss modest cardiovascular gains linked to regular sauna use and short‑term muscle recovery from cold‑water...
20/20 BioLabs Expands Longevity Test with Kidney Risk Tech
20/20 BioLabs announced an exclusive U.S. license with South Korea’s ROKIT Healthcare to embed its chronic kidney disease (CKD) prediction algorithm into the company’s OneTest for Longevity platform. The addition expands the test beyond inflammation biomarkers to provide early kidney...
Enlivex Clears Pivotal FDA Hurdle in Knee Osteoarthritis
Enlivex has secured FDA Investigational New Drug (IND) clearance to launch a global Phase 2b trial of its immunotherapy Allocetra for moderate‑to‑severe age‑related knee osteoarthritis. The study will be randomized, double‑blind, and placebo‑controlled, building on promising Phase 1/2a data from 134 patients....
Detecting Disease at Its Molecular Origin
Garage Brain Science (GBS), a Taiwan biotech, announced new clinical collaborations to develop rapid, at‑home screening tools for early metabolic stress linked to prediabetes and structural abnormalities of the TDP‑43 protein associated with neurodegenerative diseases. The company is leveraging blood‑based...
Can Medicine Outrun Aging? Gerontologist Says Odds Are Improving
Longevity Escape Velocity (LEV) founder Aubrey de Grey discussed the concept of outpacing aging on the Longevity Technology Unlocked podcast. He described LEV as repairing molecular damage to rejuvenate individuals, buying decades for further research, and highlighted mouse studies combining...
AI-Built Intrabodies Target Alzheimer’s Within
University of Essex researchers used artificial intelligence to redesign antibody fragments, creating "intrabodies" that remain stable inside human cells. By adjusting electrical charge, they converted 672 antibodies into intracellularly functional molecules that bind disease‑causing proteins linked to Alzheimer’s, Parkinson’s, Huntington’s...
Subtle Antiaging Injectables Become Allergan’s Next Bet
At AMWC 2026, Allergan Aesthetics announced a strategic pivot toward “undetectable” hyaluronic‑acid injectables, emphasizing subtle, personalized maintenance rather than dramatic transformation. The company released a consumer study of 12,000 respondents showing over 70% prefer natural‑looking, reversible results. Allergan frames this...
Diabetes Eye Damage Linked to Higher Dementia Risk
New research published in the American Journal of Ophthalmology tracked nearly 770,000 older adults and found that type 2 diabetes patients with worsening diabetic retinopathy face a markedly higher risk of dementia. Those with the most severe retinal disease had...
Private Clinics Face Longevity Learning Curve
Longevity medicine is moving from niche research into private clinics, where providers are experimenting with layered diagnostics such as genomics, imaging and deep blood panels. The Longevity Show’s new blog outlines the challenges these clinics face, including the lack of...
PREMAZ Expands Early Brain Screening Through Health Is One
PREMAZ, a Cambridge‑backed digital cognitive assessment, has partnered with UK wellness provider Health is One to embed early brain‑health screening into everyday well‑being services. The 10‑15 minute test focuses on "memory precision," detecting subtle declines that traditional tests miss. By...
Global Rallies Call for Aging to Be Treated
Fund Longevity is staging coordinated rallies in 14 cities to pressure governments into funding geroscience and recognizing aging as a treatable medical condition. The demonstrations underscore a widening gap: private capital is pouring billions into senolytics, cellular reprogramming and AI‑driven...
Lilly Races to Become First Longevity Big Pharma
Eli Lilly has signed a deal with AI‑focused biotech Insilico Medicine valued up to $2.75 billion, with $115 million paid upfront and the remainder tied to milestones. The agreement grants Lilly an exclusive worldwide license to several preclinical oral candidates and access...
Allergan Aesthetics Highlights Undetectable Era for HA Injectables
Allergan Aesthetics, an AbbVie subsidiary, announced the "undetectable era" for hyaluronic acid (HA) injectables at the Aesthetic & Anti-Aging Medicine World Congress 2026 in Monaco. The company unveiled its global research study, "Layered Beauty: The New Aesthetic Mindset," which highlights...